Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Of Metastatic Bladder Cancer at the Time Of Biochemical reLApse Following Radical Cystectomy

NCT04138628 is registered in ClinicalTrials.gov with Jørgen Bjerggaard Jensen as lead sponsor.

NCT NCT04138628
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04138628 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Of Metastatic Bladder Cancer at the Time Of Biochemical reLApse Following Radical Cystectomy
Lead sponsor
Jørgen Bjerggaard Jensen
Phase
Phase 2
Overall status
Active, not recruiting
Start date
March 24, 2020
Completion date
November 1, 2030
Enrollment
154 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, bladder cancer, metastatic